The results suggest that high levels of serum HMGB1 may lead to poor prognosis in ESCC patients, HMGB1 has higher value than IDO in predicting the prognosis of ESCC patients. The gene discussed is HMGB1; the disease is esophageal squamous cell carcinoma.